Dr. Fischer is an Independent Investigator at Dana-Farber Cancer Institute and Associate Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He is Director of the Center for Protein Degradation at Dana-Farber Cancer Institute. Dr. Fischer’s research focuses on understanding the molecular architecture, function, and regulation of complex cellular signaling machines and their involvement in cellular processes, as well as leveraging this knowledge to develop new strategies for small-molecule-mediated modulation. Dr. Fischer’s work has significantly contributed to the now widespread use of targeted protein degradation in drug discovery and research. He completed his undergraduate training at the Universities of Hamburg (Germany) and Basel (Switzerland) and completed doctoral training at the Friedrich Miescher Institute for Biomedical Research, also in Basel.
